$TWST
Twist Bioscience Corp

2021 Q4 Form 10-K Financial Statement

#000110465921142700 Filed on November 23, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021
Revenue $42.02M $37.95M $132.3M
YoY Change 49.21% 17.02% 46.87%
Cost Of Revenue $27.06M $22.50M $80.62M
YoY Change 48.97% 27.97% 31.29%
Gross Profit $14.96M $15.45M $51.71M
YoY Change 49.63% 4.0% 80.22%
Gross Profit Margin 35.61% 40.72% 39.08%
Selling, General & Admin $51.10M $38.24M $135.9M
YoY Change 77.47% 40.65% 31.6%
% of Gross Profit 341.52% 247.46% 262.8%
Research & Development $22.63M $19.44M $69.07M
YoY Change 61.64% 67.04% 60.61%
% of Gross Profit 151.25% 125.81% 133.57%
Depreciation & Amortization $3.150M $2.431M $9.800M
YoY Change 49.22% 28.62% 46.27%
% of Gross Profit 21.05% 15.73% 18.95%
Operating Expenses $73.73M $57.69M $205.0M
YoY Change 72.29% 48.6% 40.13%
Operating Profit -$55.94M -$42.23M -$152.7M
YoY Change 70.59% 76.26% 9.03%
Interest Expense $26.00K $1.862M $367.0K
YoY Change -77.97% -6306.67% -53.37%
% of Operating Profit
Other Income/Expense, Net -$156.0K -$1.065M -$1.370M
YoY Change 102.6% 1675.0% 652.75%
Pretax Income -$55.97M -$40.90M -$154.0M
YoY Change 70.35% 70.0% 10.38%
Income Tax -$10.41M $341.0K -$1.930M
% Of Pretax Income
Net Earnings -$45.56M -$41.24M -$152.1M
YoY Change 38.49% 69.58% 8.69%
Net Earnings / Revenue -108.44% -108.67% -114.94%
Basic Earnings Per Share -$0.91 -$3.15
Diluted Earnings Per Share -$912.9K -$835.5K -$3.152M
COMMON SHARES
Basic Shares Outstanding 49.63M 49.29M 48.25M shares
Diluted Shares Outstanding 49.91M shares 48.25M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $301.9M $477.9M $477.9M
YoY Change -48.6% 64.78% 64.78%
Cash & Equivalents $191.6M $465.8M $465.8M
Short-Term Investments $110.2M $12.03M $12.03M
Other Short-Term Assets $10.04M $8.283M $8.283M
YoY Change 22.4% 33.6% 33.6%
Inventory $40.24M $31.80M $31.80M
Prepaid Expenses
Receivables $32.87M $28.55M $26.21M
Other Receivables $5.834M $2.337M $2.337M
Total Short-Term Assets $385.0M $546.5M $546.5M
YoY Change -39.31% 63.2% 63.18%
LONG-TERM ASSETS
Property, Plant & Equipment $65.14M $44.12M $105.7M
YoY Change 9.47% 73.26% 78.55%
Goodwill $84.24M $22.43M
YoY Change 1871.35%
Intangibles
YoY Change
Long-Term Investments $106.8M
YoY Change
Other Assets $7.425M $7.674M $9.204M
YoY Change 72.67% 171.84% 170.71%
Total Long-Term Assets $401.2M $155.6M $155.6M
YoY Change 515.28% 143.08% 143.13%
TOTAL ASSETS
Total Short-Term Assets $385.0M $546.5M $546.5M
Total Long-Term Assets $401.2M $155.6M $155.6M
Total Assets $786.2M $702.1M $702.1M
YoY Change 12.37% 76.02% 76.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.07M $14.90M $14.90M
YoY Change 159.25% 208.49% 210.42%
Accrued Expenses $11.69M $6.437M $36.98M
YoY Change -45.65% 65.01% 46.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.552M $1.552M
YoY Change -100.0% -53.44% -52.97%
Total Short-Term Liabilities $80.03M $63.05M $63.05M
YoY Change 115.73% 75.0% 75.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $19.67M $5.068M $58.22M
YoY Change -17.7% 1343.87% 131.05%
Total Long-Term Liabilities $19.67M $5.068M $58.22M
YoY Change -19.71% 188.94% 118.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $80.03M $63.05M $63.05M
Total Long-Term Liabilities $19.67M $5.068M $58.22M
Total Liabilities $160.0M $121.3M $121.3M
YoY Change 159.72% 93.67% 93.73%
SHAREHOLDERS EQUITY
Retained Earnings -$656.1M -$610.6M
YoY Change 33.18%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $626.2M $580.8M $580.8M
YoY Change
Total Liabilities & Shareholders Equity $786.2M $702.1M $702.1M
YoY Change 12.37% 76.02% 76.01%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021
OPERATING ACTIVITIES
Net Income -$45.56M -$41.24M -$152.1M
YoY Change 38.49% 69.58% 8.69%
Depreciation, Depletion And Amortization $3.150M $2.431M $9.800M
YoY Change 49.22% 28.62% 46.27%
Cash From Operating Activities -$46.65M -$34.80M -$112.2M
YoY Change 87.12% 38.05% -21.1%
INVESTING ACTIVITIES
Capital Expenditures $12.78M -$8.089M $27.06M
YoY Change 252.25% 262.74% 174.23%
Acquisitions $8.160M $483.0K
YoY Change
Other Investing Activities -$213.8M $32.00M $183.2M
YoY Change 405.55% -134.62% -274.86%
Cash From Investing Activities -$226.6M $23.91M $156.2M
YoY Change 393.42% -125.26% -236.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $3.333M
YoY Change 0.0%
Cash From Financing Activities -1.011M 1.575M 329.2M
YoY Change -100.31% -71.72% 8.38%
NET CHANGE
Cash From Operating Activities -46.65M -34.80M -112.2M
Cash From Investing Activities -226.6M 23.91M 156.2M
Cash From Financing Activities -1.011M 1.575M 329.2M
Net Change In Cash -274.2M -9.317M 373.1M
YoY Change -207.06% -91.85% 696.43%
FREE CASH FLOW
Cash From Operating Activities -$46.65M -$34.80M -$112.2M
Capital Expenditures $12.78M -$8.089M $27.06M
Free Cash Flow -$59.44M -$26.71M -$139.3M
YoY Change 108.1% 16.25% -8.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001581280
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2058888
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
196335000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28549000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26376000
CY2021Q3 us-gaap Inventory Net
InventoryNet
31800000
CY2020Q3 us-gaap Inventory Net
InventoryNet
12289000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8283000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6203000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
546495000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
334870000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44122000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25466000
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45083000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
49499000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
CY2018Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.101
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-38720
CY2021 dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corporation
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
681 Gateway Blvd
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
CY2021 dei City Area Code
CityAreaCode
800
CY2021 dei Local Phone Number
LocalPhoneNumber
719-0671
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Trading Symbol
TradingSymbol
TWST
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Public Float
EntityPublicFloat
4885000000
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49632483
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465829000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93667000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
12034000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61580000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33699000
CY2021Q3 us-gaap Goodwill
Goodwill
22434000
CY2020Q3 us-gaap Goodwill
Goodwill
1138000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18262000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
307000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1530000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7674000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2823000
CY2021Q3 us-gaap Assets
Assets
702097000
CY2020Q3 us-gaap Assets
Assets
398882000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
14900000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4830000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6437000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3901000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22327000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14945000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8213000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6409000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1552000
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9623000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2611000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
63052000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
36029000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53156000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24837000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1403000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5068000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
351000
CY2021Q3 us-gaap Liabilities
Liabilities
121276000
CY2020Q3 us-gaap Liabilities
Liabilities
62620000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49499000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45083000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1190828000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
794630000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
546000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
87000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-610553000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-458455000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
580821000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
336262000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
702097000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
398882000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132333000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.92
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90100000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54385000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
80620000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
61406000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
47426000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69072000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43006000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35683000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
135901000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103267000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80126000
CY2021 twst Change In Fair Value Of Acquisition Consideration
ChangeInFairValueOfAcquisitionConsideration
-534000
CY2020 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
22500000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
285059000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
230179000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
163235000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-152726000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-140079000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-108850000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
435000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1499000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
3032000
CY2021 us-gaap Interest Expense
InterestExpense
367000
CY2020 us-gaap Interest Expense
InterestExpense
787000
CY2019 us-gaap Interest Expense
InterestExpense
1294000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1370000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-182000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-265000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-154028000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-139549000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-107377000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1930000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
382000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
292000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-152098000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-139931000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-107669000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-14000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-34000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
49000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
473000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
45000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-151639000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140025000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107575000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.15
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.57
CY2021 us-gaap Profit Loss
ProfitLoss
-152098000
CY2020 us-gaap Profit Loss
ProfitLoss
-139931000
CY2019 us-gaap Profit Loss
ProfitLoss
-107669000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48251000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39190000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27462000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-201422000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
153852000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2700000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2264000
CY2019 twst Conversion Of Convertible Preferred Stock Warrant
ConversionOfConvertiblePreferredStockWarrant
631000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
290462000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11170000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
94000
CY2019 us-gaap Profit Loss
ProfitLoss
-107669000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
152082000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
295563000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3428000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10539000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17096000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-94000
CY2020 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-2421000
CY2020 us-gaap Profit Loss
ProfitLoss
-139931000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
336262000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
323861000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14471000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
4944000
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
26773000
CY2021 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-10849000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
36998000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
459000
CY2021 us-gaap Profit Loss
ProfitLoss
-152098000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
580821000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9750000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6677000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6111000
CY2021 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
2243000
CY2020 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
-1043000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-189000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
36998000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17096000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
11170000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-593000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
214000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1249000
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
5000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
40000
CY2021 twst Change In Fair Value Of Acquisition Consideration
ChangeInFairValueOfAcquisitionConsideration
-534000
CY2021 us-gaap Other Noncash Expense
OtherNoncashExpense
67000
CY2020 us-gaap Other Noncash Expense
OtherNoncashExpense
152000
CY2019 us-gaap Other Noncash Expense
OtherNoncashExpense
233000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
81000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
184000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
282000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2202000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14272000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6685000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19489000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4956000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1302000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2058000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3683000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-746000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4653000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
554000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2064000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8542000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5506000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3278000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3115000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2648000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4210000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7392000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4465000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5060000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-28000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1978000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-247000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-112244000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-142255000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-87937000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27061000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9868000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14757000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
483000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
58795000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
202882000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
177574000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
242494000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
98100000
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
87500000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
156155000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-114650000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104810000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
779000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
101000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
14559000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10495000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2170000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
323861000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
295563000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
156208000
CY2021 twst Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
4944000
CY2020 twst Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
3428000
CY2019 twst Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
2700000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3333000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3333000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2500000
CY2021 twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
10849000
CY2020 twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
2421000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
329182000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
303732000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
158578000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
373113000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46848000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34139000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94246000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47398000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81537000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
467359000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94246000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47398000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
167000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
438000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
172000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
291000
CY2021 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
2011000
CY2020 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1333000
CY2019 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
170000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33617000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3718000
CY2019 twst Conversion Of Convertible Preferred Stock Warrant
ConversionOfConvertiblePreferredStockWarrant
631000
CY2019 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
290462000
CY2021 us-gaap Stock Issued1
StockIssued1
26773000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-610600000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Concentration of credit risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, short-term investments and accounts receivable. Substantially all of the Company’s cash is held by one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company’s investment policy addresses the level of credit exposure by establishing a minimum allowable credit rating and by limiting the concentration in any one investment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;">The Company’s accounts receivable is derived from customers located principally in the United States and Europe. The Company performs ongoing credit evaluations of its customers and maintains allowances for potential credit losses on customers’ accounts when deemed necessary. The Company does not typically require collateral from its customers. Credit losses historically have not been material. The Company continuously monitors customer payments and maintains an allowance for doubtful accounts based on its assessment of various factors including historical experience, age of the receivable balances, and other current economic conditions or other factors that may affect customers’ ability to pay.</p>
CY2021 twst Credit Period Granted To Customers
CreditPeriodGrantedToCustomers
P30D
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9800000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6700000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6100000
CY2021Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3000000.0
CY2020Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2400000
CY2021 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
2000000.0
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1100000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
2500000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
1200000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
1300000
CY2020 twst Common Stock Warrants Issued During Period
CommonStockWarrantsIssuedDuringPeriod
0
CY2021 twst Common Stock Warrants Issued During Period
CommonStockWarrantsIssuedDuringPeriod
0
CY2021Q3 twst Cash And Cash Equivalents At Amortized Cost
CashAndCashEquivalentsAtAmortizedCost
465829000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465829000
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12033000
CY2021 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
1000
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
12034000
CY2021Q3 twst Cash And Cash Equivalents And Short Term Investments Amortized Cost
CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
477862000
CY2021 twst Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
1000
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
477863000
CY2020Q3 twst Cash And Cash Equivalents At Amortized Cost
CashAndCashEquivalentsAtAmortizedCost
93667000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93667000
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
196320000
CY2020 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
15000
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
196335000
CY2020Q3 twst Cash And Cash Equivalents And Short Term Investments Amortized Cost
CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
289987000
CY2020 twst Available For Sale Securities Gross Unrealized Gain Loss
AvailableForSaleSecuritiesGrossUnrealizedGainLoss
15000
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
290002000
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
442472000
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
9856000
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
269748000
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
26549000
CY2020Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
25790000
CY2021Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
2337000
CY2020Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
951000
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
337000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
365000
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28549000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26376000
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
18778000
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
9237000
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
4837000
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2021000
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8185000
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1031000
CY2021Q3 us-gaap Inventory Net
InventoryNet
31800000
CY2020Q3 us-gaap Inventory Net
InventoryNet
12289000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1900000
CY2021Q3 twst Other Assets Noncurrent Excluding Convertible Receivable
OtherAssetsNoncurrentExcludingConvertibleReceivable
4653000
CY2020Q3 twst Other Assets Noncurrent Excluding Convertible Receivable
OtherAssetsNoncurrentExcludingConvertibleReceivable
2823000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
79544000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54944000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35422000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29478000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44122000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25466000
CY2021Q3 twst Convertible Note Receivable
ConvertibleNoteReceivable
3021000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7674000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2823000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5057000
CY2020Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2444000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1380000
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1457000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6437000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3901000
CY2021Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
4643000
CY2020Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3641000
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
8584000
CY2020Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5747000
CY2021Q3 twst Accrued Commissions Current
AccruedCommissionsCurrent
3330000
CY2020Q3 twst Accrued Commissions Current
AccruedCommissionsCurrent
1970000
CY2021Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4676000
CY2020Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2711000
CY2021Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
1094000
CY2020Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
876000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22327000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14945000
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
5186000
CY2021Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
2440000
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
719000
CY2021Q3 twst Other Liabilities Current Other Than Contingent Consideration And Taxes
OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes
1997000
CY2020Q3 twst Other Liabilities Current Other Than Contingent Consideration And Taxes
OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes
1892000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9623000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2611000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
21300000
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18400000
CY2020 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19650000
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1388000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18262000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
933000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
307000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1593000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1138000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1053000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1053000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1053000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
12372000
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18262000
CY2017 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
interest rate of prime plus 3.0%
CY2021 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
100000
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
833000
CY2021Q3 twst Long Term Debt Maturities Interest Payable In Next Twelve Months
LongTermDebtMaturitiesInterestPayableInNextTwelveMonths
9000
CY2021Q3 twst Long Term Debt Maturities Repayment Principal And Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentPrincipalAndInterestInNextTwelveMonths
842000
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
833000
CY2021Q3 twst Interest Payable On Long Term Debt
InterestPayableOnLongTermDebt
9000
CY2021Q3 twst Long Term Debt Maturities Repayment Principal And Interest Total
LongTermDebtMaturitiesRepaymentPrincipalAndInterestTotal
842000
CY2021Q3 twst Interest Payable On Long Term Debt
InterestPayableOnLongTermDebt
9000
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
833000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4000
CY2021Q3 twst Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
723000
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1552000
CY2021 us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
CY2021 us-gaap Lessor Operating Lease Existence Of Option To Terminate
LessorOperatingLeaseExistenceOfOptionToTerminate
true
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61580000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8213000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53156000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8986000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10595000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
10333000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10489000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9083000
CY2021Q3 twst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
84753000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
134239000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
55242000
CY2021Q3 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
17628000
CY2021Q3 twst Operating Lease Liability Net Of Improvement Allowance
OperatingLeaseLiabilityNetOfImprovementAllowance
61369000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9000000.0
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8213000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53156000
CY2020 twst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
2100000
CY2021 twst Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
27900000
CY2021 twst Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
30100000
CY2020 twst Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
3100000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
9500000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
7900000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
8000000.0
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P17Y3M18D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.064
CY2021 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
5000000.0
CY2020 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
3400000
CY2019 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
3200000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1900000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-149533000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-138016000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-107847000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-4495000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1533000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
470000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-154028000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-139549000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-107377000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-29000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
382000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
184000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
108000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
108000
CY2021Q3 twst Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
14890000
CY2021 twst Effective Income Tax Rate Reconciliation Business Combination Percent
EffectiveIncomeTaxRateReconciliationBusinessCombinationPercent
-0.02
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
79000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
382000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
292000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2268000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
259000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2009000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1930000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
382000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
292000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.33
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.25
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.22
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.03
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.12
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.03
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
163782000
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
112434000
CY2021Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
20163000
CY2020Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9407000
CY2020Q3 twst Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
7506000
CY2021Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
11631000
CY2020Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5639000
CY2021Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
210466000
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
134986000
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
190428000
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
127336000
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
20038000
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7650000
CY2021Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
785000
CY2020Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
105000
CY2021Q3 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
14893000
CY2020Q3 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
7498000
CY2021Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4360000
CY2020Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
47000
CY2021Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
20038000
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7650000
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
190400000
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
127300000
CY2021 twst Tax Credit
TaxCredit
2033
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2249000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1042000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3291000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1409000
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4700000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2737000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7437000
CY2021Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
100000
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
26385
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
18854
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
14.85
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
16051
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
7531
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
21.24
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.644
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.621
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.602
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
6041
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2021Q3 twst Share Based Compensation Arrangement By Share Based Payment Award Right Of Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardRightOfRepurchase
2741
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
26300000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36998000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17096000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11170000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.027
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
42.80
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.76
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.06
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-152098000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-139931000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-107669000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48251000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39190000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27462000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.15
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.57
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.92
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3868000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4593000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4177000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132333000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90100000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54385000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132333000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90100000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54385000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132333000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90100000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54385000

Files In Submission

Name View Source Status
R2.htm Edgar Link pending
0001104659-21-142700-index-headers.html Edgar Link pending
0001104659-21-142700-index.html Edgar Link pending
0001104659-21-142700.txt Edgar Link pending
0001104659-21-142700-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20210930.xsd Edgar Link pending
twst-20210930x10k.htm Edgar Link pending
twst-20210930x10k004.jpg Edgar Link pending
twst-20210930x10k007.jpg Edgar Link pending
twst-20210930x10k008.jpg Edgar Link pending
twst-20210930x10k009.jpg Edgar Link pending
twst-20210930x10k010.jpg Edgar Link pending
twst-20210930x10k011.jpg Edgar Link pending
twst-20210930x10k012.jpg Edgar Link pending
twst-20210930x10k_htm.xml Edgar Link completed
twst-20210930xex21d1.htm Edgar Link pending
twst-20210930xex23d1.htm Edgar Link pending
twst-20210930xex31d1.htm Edgar Link pending
twst-20210930xex31d2.htm Edgar Link pending
twst-20210930xex32d1.htm Edgar Link pending
twst-20210930xex32d2.htm Edgar Link pending
twst-20210930_cal.xml Edgar Link unprocessable
twst-20210930_def.xml Edgar Link unprocessable
twst-20210930_lab.xml Edgar Link unprocessable
twst-20210930_pre.xml Edgar Link unprocessable